CD3+TCRValpha7.2 + T cell culture medium and multiplication culture method

A technology of expansion culture and culture medium, applied in the field of CD3+TCRVα7.2+T cell culture medium and expansion culture, it can solve the problems of low proportion of MAIT cells, easy pollution, difficult operation, etc., and achieve high cell purity, The effect of high cell viability and reduced background value

Active Publication Date: 2022-03-01
EAST CHINA NORMAL UNIV +1
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Generally, MAIT cells are sorted from PBMC, and most of them are enriched by magnetic bead sorting and then flow sorted. However, this method has obvious disadvantages: the proportion of MAIT cells is low, and the flow sorter sorts cells The required experiment is longer, and the cells are exposed to the external environment during the whole process, which is easy to be polluted; the total amount of cells obtained is small, and it is difficult to expand
This kind of basal medium is very difficult to cultivate MAIT cells. According to the relevant literature [3], at present, most MAIT cells can only be expanded by about 30 times within 21 days.
3) In order to increase the amplification factor of cells, various factors (such as IL-2, IL-7, IL-15, IL-12, IL-18) and chemical reagents (such as specific antigen 5- OP-RU / 5-OE-RU, 1% penicillin-streptomycin, 10mM HEPES buffer, 0.1mM MEM non-essential amino acids, 1mM sodium pyruvate and 5.5mM 2-mercaptoethanol, etc.), but these culture methods are expensive High, and it is easy for cells to enter a mature state, which is not conducive to the continuous expansion of cells and later functional tests and clinical research
[0013] In summary, the purification, activation and expansion methods of MAIT cells have the characteristics of high cost and difficult operation

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • CD3+TCRValpha7.2 + T cell culture medium and multiplication culture method
  • CD3+TCRValpha7.2 + T cell culture medium and multiplication culture method
  • CD3+TCRValpha7.2 + T cell culture medium and multiplication culture method

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0066] A. Take fresh PBMCs and place them in a 50mL centrifuge tube. If they are revived PBMCs, resuspend the cells in RPMI1640 medium containing 5-10% FBS at a density of 0.5E+06-2E+06 / mL. The flasks were incubated for 6 hours. Then resuspend with 10mL PBS, centrifuge at 1500rpm at a speed of liters 9 to 9 for 5 minutes, discard the supernatant, and repeat once.

[0067] B. Add an appropriate amount of sorting solution, mix well and count with trypan blue, and take 1E+06 cells at the same time, and measure the proportion of CD3+TCRVα7.2+T cells before sorting with a flow cytometer, see Figure 4 .

[0068] C. Add CD3 MicroBeads, human (Miltenyi Biotec) at an amount of 3 to 20 μL for every 0.5E+07 to 2E+07 cells, up to 100 μL, and add 80 to 120 μL for every 0.5E+07 to 2E+07 cells Add the sorting solution in an appropriate amount and mix the cells evenly.

[0069] D. Place the above-mentioned centrifuge tube with cells at 4°C, incubate in the dark for 15-30 minutes, take it ...

Embodiment 2

[0078] A. Take the PBMC in step S1, wash off the excess residue with PBS, discard the supernatant, add PBS to resuspend, count with trypan blue, adjust the density to 1E+07~3E+07 / 100μL, take 1E +06 cells were used as a negative control, and 0.5-5 μL of anti-human CD45 (Biolegend), anti-human CD3 antibody (Biolegend), anti-human TCRVα7.2 antibody (Biolegend) and anti-human CD161 antibody (Biolegend) were added to each 100 μL ), mix well and incubate at room temperature for 10-30 minutes.

[0079] B. Add 10 mL of PBS, centrifuge at a speed of 1500 rpm for 5 minutes, discard the supernatant, and repeat once.

[0080] C. Cells were resuspended in T009 medium containing 3-10% FBS and 0.5-3% double antibody, and the density was 5E+06-3E+07 / mL.

[0081] D. Use BD Influx flow sorting instrument, adopt four-way sorting, collect CD45+CD3+TCRVα7.2+CD161+, CD45+CD3+TCRVα7.2+CD161-, CD45+CD3+TCRVα7.2-CD161- three kind of cells. The purity of the collected cells was detected by a flow cy...

Embodiment 3

[0083] A. Take the PBMC in step S1, wash away the excess residue with PBS, discard the supernatant, add PBS to resuspend, count with trypan blue, first use magnetic beads to sort out CD3+ T cells, and then add 5~ Centrifuge 15mL PBS at 1500rpm at a speed of liters 9 to 9 for 5 minutes, discard the supernatant, and repeat once.

[0084] B. Add an appropriate amount of PBS, adjust the density to 0.5E+07~3E+07 / 100μL, take 1E+06 cells as a negative control, add 0.5~5μL of anti-human CD3 antibody (Biolegend), anti -human TCRVα7.2 antibody (Biolegend) and anti-human CD161 antibody (Biolegend), mix well and incubate at room temperature for 10-30 minutes.

[0085] C. Add 5-15mL PBS, centrifuge at 1500rpm at a speed of 9 to 9 for 5 minutes, discard the supernatant, and repeat once.

[0086] D. Resuspend in T009 medium containing 3-10% FBS and 0.5-3% double antibody, and the density is 5E+06-3E+07 / mL.

[0087] E. Using a BD Influx flow sorter, four-way sorting was used to collect CD3+...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a CD3 + TCRV alpha7.2 + T cell culture medium and a cell multiplication culture method. According to the culture medium, a basic culture medium contains 3%-10% of FBS, 10 U / mL to 50 U / mL of IL-2 and 10 ng / mL to 50 ng / mL of IL-15; the basic culture medium is selected from one or more of an RPMI 1640 culture medium, a T009 culture medium, an AIMV culture medium, a DMEM culture medium and an X-VIVO culture medium. A new technical route for obtaining and purifying the T cell subtype CD3 + TCRV alpha7.2 + T cell is developed, the culture medium is low in economic cost and simple to operate, the cell amplification multiple can be adjusted to be close to that of conventional T cells within a certain time period, and the common problem that the amplification difficulty of the CD3 + TCRV alpha7.2 + T cell is large is solved.

Description

technical field [0001] The invention belongs to the biological field, and in particular relates to a CD3+TCRVα7.2+T cell culture medium and a method for expanding and culturing. Background technique [0002] At present, there are few studies on CD3+TCRVα7.2+ T cells, but MAIT cells (whose phenotype is CD3+TCRVα7.2+CD161+) are mainly obtained and cultured in the following ways: [0003] i. Take fresh peripheral blood (PBMC) from healthy volunteers, use antibody-Microbeads coupling to sort CD161+ cells, immediately stain the separated cells with antibodies, and use flow sorting to obtain CD3+ TCRVα7.2+CD161+ cells are cultured in complete medium (50% AIMV+50% RPMI1640+10% FBS+glutamine+β-mercaptoethanol), and the cell density ranges from 5E+05 to 2E+06 cells / mL , the incubator environment is 37°C, 5% CO 2 (Lu Yongyong, Research on the number, function and anti-tumor effect of mucosa-associated invariant T cells (MAIT) in patients with bladder cancer, 2017 dissertation, Shand...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C12N5/0783
CPCC12N5/0636C12N2501/2302C12N2501/2315C12N2500/32C12N2501/2307C12N2501/2312C12N2501/2318C12N2501/515C12N2501/51C12N2509/00
Inventor 贾裕杰徐南康立清俞磊谭靖雯叶晶方小燕王依婷
Owner EAST CHINA NORMAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products